麝香通心滴丸联合尼可地尔对冠心病心绞痛患者心绞痛发作及心功能的影响
2025-08-09李婧孙暮燕温春琪
The Effect of Shexiang Tongxin Dripping Pils Combined with Nicorandil on Angina Pectoris amp; Cardiac Function inPatients with Coronary Heart Diseaseand Angina Pectoris/LI Jing,SUN Aoyan,W Chunqi. //Medical Innovation of China,2025, 22(16): 081-085
[Abstract]Objective: To investigate the effects of using Shexiang Tongxin Dripping Pills combined with Nicorandil on the incidence of angina pectoris and cardiac function in patients with coronary heart disease and angina pectoris.Method:A retrospective analysis was conducted on the clinical data of 8O patients with coronary heartdisease andangina pectorisadmitted tothe Shenyang Medical Collge Afiliated Central Hospital from January 2022 to December 2023.According to diferent treatment methods,they were divided into two groups.The control group ( n =40) was treated with Nicorandil,and the experimental group ( n =40)was treated with Shexiang Tongxin Dropping Pils inaddition to Nicorandil on the basisof the treatmentof thecontrol group.Theclinical efficacy, episodes ofangina pectoris,andcardiac function indicators between two groups were compared,and the incidence of adverse reactions between the two groups was counted.Result: Compared with the control group,the total effectiverate of the experimental group was significantly higher,the diference was statistically significant ( P lt;0.05). Compared with the control group,the experimental group had significantly fewer frequency and shorter duration of angina pectoris after treatment,and showed significantly beter changes inthe S-Tsegment,the diferences were statistically significant ( P- lt;0.05). Compared with the control group,the experimental group had significantly higherleft ventricular ejection fraction(LVEF)and stroke volume (SV) after treatment,and significantly lower left ventricular end systolic diameter(LVESD)and leftventricular end diastolic diameter(LVEDD),the diferences were statistically significant ( P lt;0.05). Comparison of the incidence of adverse reactions between the two groups, the difference was not statistically significant Pgt;0.05 ).Conclusion:For patients with coronary heart disease and angina pectoris,the combination therapyof Shexiang Tongxin Dripping Pills and Nicorandilcan efectively reduce the frequency of angina pectoris,shortenthe durationof angina pectoris,promote therecovery of patients'cardiac function indicators,and has high safety.
[Key Words] Coronary heart diseaseAngina pectorisShexiang Tongxin Dripping PilsNicorandil Heart function
First-author'saddress:Department ofCardiovascularMedicine,Shenyang Medical Colege Affiliated entralHospital,Shenyang11oooo,China
doi: 10.3969/j.issn.1674-4985.2025.16.020
冠心病属于临床多发病,其发病机制在于心肌缺血、缺氧,可导致患者出现不同程度的心前区绞痛症状,对患者生活及工作造成较大影响,若心绞痛发作未得到及时治疗,还可能会诱发心肌大面积梗死,严重者甚至导致死亡[1-2]。临床对冠心病心绞痛患者通常采取药物治疗,尼可地尔兼具硝酸酯基团、钾通道开放特性双重作用机制,可通过激活鸟苷酸环化酶-环磷酸鸟苷(cGMP)通路,扩张冠状动脉,抑制血管痉挛,但长期单药治疗可能诱发药物耐受性增加、血流动力学波动等不良反应,存在加速病情恶化的潜在风险[3]。中医在“心痛”“胸痹”等病治疗中积累了大量临床经验,而麝香通心滴丸作为中药复方制剂,其活性成分人工牛黄、麝香、人参茎叶总皂苷等具有活血化癖、通脉止痛之效,可起到良好的抗炎、改善血管内皮功能及抑制心肌重构等多重药理效应,对治疗本病具有积极价值[4。鉴于此,本研究采用麝香通心滴丸联合尼可地尔进行治疗,旨在通过多靶点协同干预模式探索联合用药的临床价值,现报道如下。
1资料与方法
1.1一般资料
回顾性分析医学院附属中心医院2022年1月一2023年12月收治的80例冠心病心绞痛患者的临床资料。诊断标准:(1)西医符合文献[5]《心血管疾病诊断治疗学》中的相关诊断标准;经心电图等检查后确诊。(2)中医符合文献[6]《冠心病心绞痛主要证型的辨证诊断标准》中的相关诊断标准;证型:气虚血瘀型,以胸痛、胸闷、气短喘促为主证,以心悸、眩晕、四肢寒冷为次证,以舌质紫黯、苔浊腻、脉涩/滑为舌脉象。……
